Clinical Trial Update: A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A Pfizer-sponsored clinical trial update describing a study of Vepdegestrant in combination with PF-07220060 for advanced or metastatic breast cancer (Phase 1/P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PF-07220060
• Vepdegestrant (ARV-471)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING